自然冻融胚胎移植妊娠中孕酮补充的围产期结局:来自2项随机对照试验的见解
基于瑞典2所大学医院2008-2011年与2013-2018年2项随机对照试验的二次分析,纳入自然冻融胚胎移植后单胎活产的227例,比较黄体期阴道孕酮补充至孕8周与不补充的围产期结局,发现孕酮补充组正常出生体重儿比例更高,妊娠期高血压疾病发生率数值上更低但未达统计学显著,未观察到其他主要不良围产结局差异。
要点
- 孕酮补充组正常出生体重儿比例为82.4%,不补充组为70.3%。
- 孕酮补充组妊娠期高血压疾病发生率为4.4%,不补充组为11.1%,差异未达统计学显著。
- 未观察到其他主要不良产科或新生儿结局差异,孕酮补充与某些围产结局的关联需进一步研究。
核心结论
- 研究显示自然冻融胚胎移植周期黄体期及早期妊娠使用阴道孕酮补充未伴有不良围产期影响,孕酮补充与某些围产结局的关联需进一步研究。
研究设计与样本
- 基于2008-2011年和2013-2018年在瑞典2所大学医院开展的2项随机对照试验的二次数据分析。
- 共923例自然冻融胚胎移植周期女性,本研究纳入治疗后妊娠并单胎活产者227例。
主要发现
- 孕酮补充组母亲年龄略高于不补充组,两组在不孕诊断、受精方式、胚胎阶段和移植胚胎数方面具有可比性。
- 孕酮补充组正常出生体重儿比例为82.4%,不补充组为70.3%。
- 孕酮补充组妊娠期高血压疾病发生率为4.4%,不补充组为11.1%,差异未达统计学显著。
- 逻辑回归分析呈现相似模式,其他主要不良产科或新生儿结局未见差异。
关键数值与推荐
- 研究参与者随机接受黄体期阴道孕酮补充至孕8周(n=136)或不补充孕酮的标准治疗(n=91)。
- 计算了发生妊娠期高血压疾病的优势比及95%置信区间,模型1调整人口学特征,模型2调整人口学及体外受精治疗变量。
临床怎么用
- 原文未据此给出推荐。
局限性
- 孕酮补充与某些围产结局的关联需进一步研究。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To explore whether progesterone supplementation during luteal phase and early pregnancy after a natural frozen-thawed embryo transfer (NC-FET) cycle affects perinatal outcomes. DESIGN: A secondary data analysis study on the basis of 2 randomized control trials taking place during 2008-2011 and 2013-2018 at 2 university hospitals in Sweden. SUBJECTS: A total of 923 women undergoing an NC-FET cycle. The present study included all women who became pregnant after treatment and delivered a single live-born infant (N = 227). INTERVENTIONS: Study participants were randomized to receive luteal phase vaginal progesterone supplementation until gestational week 8 (n = 136) or to the standard of care that was no progesterone supplementation (n = 91). MAIN OUTCOME MEASURES: We assessed the incidence of obstetric and neonatal outcomes. Furthermore, we calculated the odds ratios with 95% confidence intervals representing the likelihood of developing gestational hypertensive disorders. Odds ratios were adjusted for participants' demographics (model 1) or both demographic and in vitro fertilization treatment variables (model 2). RESULTS: Apart from a slightly higher maternal age in the group receiving progesterone supplementation, the subjects in both groups were otherwise comparable in terms of infertility diagnosis, fertilization mode, embryo stage, and number of embryos transferred. Our results revealed a higher proportion of infants delivered with birth weights in the normal range after progesterone supplementation (82.4% vs. 70.3% respectively). Furthermore, pregnancies after progesterone supplementation in NC-FET cycles showed a numerically lower incidence of gestational hypertensive disorders; however, this difference did not reach statistical significance (4.4% vs. 11.1%). A similar pattern was noted in the logistic regression analyses performed. No differences were observed regarding other major adverse obstetric or neonatal outcomes. CONCLUSION: Our study demonstrates the absence of harmful perinatal effects associated with the use of vaginal progesterone supplementation at the luteal phase and early pregnancy of an NC-FET cycle. These findings have increased generalizability across other populations and are particularly significant given the growing utilization of cryopreservation and freeze-all practice in assisted reproduction. The associations noted between progesterone supplementation and certain perinatal outcomes warrant further investigation.
引用
- Elenis E, Joelsson LS, Stavreus-Evers A, et al. Perinatal outcomes of progesterone in natural frozen-thawed embryo transfer pregnancies: insights from 2 randomized controlled trials. Fertil Steril. 2024. PMID: 39722356. doi:10.1016/j.fertnstert.2024.12.022
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。